204 results
Page 5 of 11
6-K
EX-99.2
idk08j85da6squr 5iyd
8 Sep 20
Replicel Life Sciences Inc. Announces Application for a Management Cease Trade Order
1:17pm
6-K
EX-99.1
7yjor4sglkvn
8 Sep 20
Form 6K for May 2020
1:15pm
6-K
EX-99.2
ofxu aaxs
8 Sep 20
Form 6K for May 2020
1:15pm
6-K
EX-99.1
wazv2ujtzuh62v0ltdr1
3 Aug 20
Consolidated Financial Statements
12:00am
6-K
EX-99.1
8k28vl7v p7js6wp
31 Jul 20
Condensed Consolidated Interim Financial Statements
9:14pm
6-K
EX-99.1
y5ko8ogrb ydz
22 Apr 20
Replicel Postpones Filing of Annual Financial Statements and MD&A Due to COVID-19 Related Delays
1:56pm
6-K
EX-99.1
u2tlzzu
23 Dec 19
RepliCel Announces its Incoming Board of Directors
5:21pm
6-K
EX-99.1
6k6ova87hwid6rujh
26 Nov 19
RepliCel Provides 2019 Year-End Update
12:41pm
6-K
EX-99.5
6eqsx5gby2vr
6 Nov 19
Notice of Annual General and Special Meeting of Shareholders
12:00am
6-K
EX-99.1
1jhln
6 Nov 19
Notice of Annual General and Special Meeting of Shareholders
12:00am
6-K
EX-99.1
dsdgpehsutyqeub
24 Sep 19
Current report (foreign)
1:49pm
6-K
EX-99.2
yo6h89 spj
20 Sep 19
51-102F3 Material Change Report
1:31pm
6-K
EX-99.3
w1vjh7p 7jm
11 Sep 19
51-102F3 Material Change Report
12:13pm
6-K
EX-99.2
401gnb6 99
11 Sep 19
51-102F3 Material Change Report
12:13pm
6-K
EX-99.1
znxyfk2v8tq7aud
10 Sep 19
RepliCel's Partner, YOFOTO (China) Health, Unveils its Inaugural Cell Therapy Manufacturing Facility in China
11:22am
6-K
EX-99.1
onawtd1
29 Aug 19
RepliCel Life Sciences Retains Dermatology Sales and Marketing Executive to Guide the Global Commercial Strategy for its Automated Dermal Injector
11:47am
6-K
EX-99.1
jl8rr paqaw3tpndo1r
26 Mar 19
Current report (foreign)
1:45pm
6-K
EX-99.1
k009utud zjdblaw49
6 Mar 19
51-102F3 Material Change Report
4:53pm